TURANLİ, S. Et Al. 2022. Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition. ACS OMEGA , vol.7, no.41 , 36354-36365.

TURANLİ, S., Ergul, A. G., Jordan, P. M., OLĞAÇ, A., ÇALIŞKAN, B., Werz, O., ... BANOĞLU, E.(2022). Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition. ACS OMEGA , vol.7, no.41, 36354-36365.

TURANLİ, SÜMEYYE Et Al. "Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition," ACS OMEGA , vol.7, no.41, 36354-36365, 2022

TURANLİ, SÜMEYYE Et Al. "Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition." ACS OMEGA , vol.7, no.41, pp.36354-36365, 2022

TURANLİ, S. Et Al. (2022) . "Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition." ACS OMEGA , vol.7, no.41, pp.36354-36365.

@article{article, author={SÜMEYYE TURANLİ Et Al. }, title={Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition}, journal={ACS OMEGA}, year=2022, pages={36354-36365} }